Modulation of CDK2-AP1 (p12(DOC-1)) expression in human colorectal cancer

Ziquan Yuan1, Anu G Gaba, Tara Sotsky Kent

  • 1Department of Molecular Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Ullmann 707, New York, NY 10461, USA.

Oncogene
|April 5, 2005
PubMed

Insights

Microsatellite instability in colorectal cancer (CRC) is linked to mutations in the CDK2-AP1 gene, reducing its expression. Restoring CDK2-AP1 levels impacts CRC cell proliferation and apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Microsatellite instability (MSI) is a hallmark of certain colorectal cancers (CRC).
  • Decreased expression of CDK2-AP1 (p12(DOC-1)) is observed in MSI CRC.
  • CDK2-AP1 modulates cell cycle arrest and apoptosis.

Purpose of the Study:

  • Investigate mechanisms of reduced CDK2-AP1 expression in MSI CRC.
  • Further elucidate the role of CDK2-AP1 in CRC cell proliferation and apoptosis using RNA interference (RNAi).

Main Methods:

  • Screened 24 CRC cell lines for mutations in the 3' poly (T)8 region of the CDK2-AP1 gene using direct sequencing.
  • Utilized an in vitro human mismatch repair (MMR) system to assess mutation correction and CDK2-AP1 expression changes after hMLH1 transfection.
  • Modulated CDK2-AP1 expression via RNAi and overexpression in various CRC cell contexts.

Main Results:

  • A del T poly (T)8 mutation in the CDK2-AP1 gene was identified in 25% of MSI CRC cell lines but not in microsatellite-stable (MSS) lines.
  • Induction of wild-type MLH1 in an in vitro system reversed the del T mutation and increased CDK2-AP1 expression.
  • RNAi-mediated CDK2-AP1 inhibition led to decreased apoptosis and increased proliferation in CRC cells lacking endogenous CDK2-AP1 deficiency.

Conclusions:

  • Mutations in the CDK2-AP1 microsatellite-like sequence contribute to reduced CDK2-AP1 expression in MSI CRC.
  • Modulating CDK2-AP1 expression significantly affects cell proliferation and apoptosis in human colorectal cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...